A review of paclitaxel (Taxol) administration, stability, and compatibility issues.
The purpose of this article is to review information relative to the administration, stability, and compatibility of paclitaxel (Taxol, Mead Johnson Oncology Products, Princeton, NJ). The unique formulation used to solubilize paclitaxel has led to an increased awareness of plasticizer-leaching issues, paclitaxel stability in solution, and paclitaxel compatibility with other medications. Particularly with longer paclitaxel infusion schedules (greater than 48 hours), both drug stability in solution and pump apparatus congruence require careful consideration to minimize plasticizer-leaching problems and to ensure optimum drug delivery. Despite knowledge of the physical compatibility of paclitaxel with numerous drugs, a paucity of research has documented the specifics of paclitaxel's chemical compatibility with other medications.
Boyle
D A
DA
Inova Fairfax Cancer Center, Falls Church, VA, USA.
Goldspiel
B R
BR
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000737:chemistry*; D004344:Drug Incompatibility; D004355:Drug Stability; D006801:Humans; D007262:Infusions, Intravenous / Q000295:instrumentation; D009859:Oncology Nursing; D017239:Paclitaxel / Q000008:administration & dosage* / Q000737:chemistry*; D010969:Plastics / Q000737:chemistry; D013997:Time Factors
D000972:Antineoplastic Agents, Phytogenic; D010969:Plastics; D017239:Paclitaxel